Association of initial response to prednisone treatment in childhood acute lymphoblastic leukaemia and polymorphisms within the tumour necrosis factor and the interleukin-10 genes.
about
Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapyUnsupervised proteome analysis of human leukaemia cells identifies the Valosin-containing protein as a putative marker for glucocorticoid resistance.The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment.TNF-α promoter polymorphisms and risk of recurrence in patients with squamous cell carcinomas of the nonoropharynxBET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia.Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes.Human leukocyte antigen-DRB1 polymorphism in childhood acute lymphoblastic leukemiaFrom pharmacokinetics to pharmacogenomics: a new approach to tailor immunosuppressive therapy.Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia.Pharmacogenetics of acute lymphoblastic leukemia treatment response.The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia.Pharmacogenetics in acute lymphoblastic leukemia.Pharmacogenetic considerations for acute lymphoblastic leukemia therapies.Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome.Polymorphisms in the TNFA gene promoter region show evidence of strong linkage disequilibrium with HLA and are associated with delayed neutrophil engraftment in unrelated donor hematopoietic stem cell transplantation.Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol.Influence of IL10 (G1082A) and TNFα (G308A) Polymorphisms on the Survival of Pediatric Patients with ALLTGFβ and IL10 have an impact on risk group and prognosis in childhood ALL.Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease.Expression of heat-shock protein 90 in glucocorticoid-sensitive and -resistant childhood acute lymphoblastic leukaemia.Immunosurveillance of childhood ALL: polymorphic interferon-gamma alleles are associated with age at diagnosis and clinical risk groups.The MIF-173G/C polymorphism does not contribute to prednisone poor response in vivo in childhood acute lymphoblastic leukemia.Effects of glucocorticoid treatment on CD25⁻FOXP3⁺ population and cytokine-producing cells in rheumatoid arthritis.TNF-α SNP rs1800629 and risk of relapse in childhood acute lymphoblastic leukemia: relation to immunophenotype.
P2860
Q28083449-2B45F46E-E6B8-4BF4-A088-C8F957AC4A92Q33236691-EEF955C9-6DD4-44F4-A9B2-19DAFC2C9CB4Q33632120-8806626D-987B-4476-9CB4-0F16E829CAB7Q33934998-3F317146-43BB-4E59-B0A0-E92EC0A9AC8FQ34358853-3418EEEF-3E4D-4FB0-AAA5-67107C012A87Q34418858-97E48D28-1EC1-4512-A31D-761D8951EA8BQ35180032-CAE2AD98-B68C-4CF7-8D5B-664B4E0B85A6Q35666588-52711B67-9B87-4780-B156-EC21116F003CQ35772582-06E3EBA9-5B49-4EA9-BE49-41B2B4A5A976Q36968156-399EF9D9-EC95-4F5E-82E2-880021DE7927Q37090821-F351C7F7-65D5-4F80-A3ED-C0E5B0741809Q37150913-0935699E-9E06-498B-96A3-1197D63D1421Q38199738-47CF8270-4329-4BB3-97BB-46DB380624F0Q38595273-049C0250-FFAA-4605-807D-F6F9181B28ACQ40563610-B0E00522-CBA3-44A2-88E6-B683508D0158Q41068390-71901470-7EDE-4E84-AF6B-9DFA17371CC4Q41723896-A8A0763F-10DF-41DF-944E-589E6890FA7DQ41724050-390AC45A-707E-4AA2-ACAE-14B896ACF5F8Q42703436-D842FB50-86BA-42AF-A588-FACD6C89B030Q44529449-38336FFD-2F11-4C27-BDDB-755EDC5119A3Q45117344-630F6063-9F05-40CA-8667-D35313B35C87Q46738593-3CA8D8AD-3106-4138-8034-E667AC188147Q47983201-DD3915F8-F849-4999-AB63-0D7874E6E6A5Q52877127-EA1252A3-3AF7-47E1-85FA-42E263798DC2
P2860
Association of initial response to prednisone treatment in childhood acute lymphoblastic leukaemia and polymorphisms within the tumour necrosis factor and the interleukin-10 genes.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Association of initial respons ...... and the interleukin-10 genes.
@en
Association of initial respons ...... and the interleukin-10 genes.
@nl
type
label
Association of initial respons ...... and the interleukin-10 genes.
@en
Association of initial respons ...... and the interleukin-10 genes.
@nl
prefLabel
Association of initial respons ...... and the interleukin-10 genes.
@en
Association of initial respons ...... and the interleukin-10 genes.
@nl
P2093
P356
P1433
P1476
Association of initial respons ...... and the interleukin-10 genes.
@en
P2093
P2888
P304
P356
10.1038/SJ.LEU.2402545
P577
2002-08-01T00:00:00Z